Table 1 Clinical and demographic characteristics of the sample.
Characteristic | Survival (N = 170) | Death (N = 14) | p value |
---|---|---|---|
Age (years, median [IQR]) | 54.5 [24.6] | 65.6 [15.3] | 0.0076 |
Sex at birth (male, N [%]) | 112 [65.9] | 12 [85.7] | 0.15 |
ICU treatment required (yes, N [%])a | 13 [7.6] | 12 [85.7] | < 0.0001 |
Virus variant | 0.00021 | ||
Original (N [%]) | 46 [27.1] | 11 [78.6] | |
B1.1.7 (alpha, N [%]) | 31 [18.2] | 0 [0] | |
B1.351 (beta, N [%]) | 0 [0] | 1 [7.1] | |
B.1.617 (delta, N [%])b | 29 [17.1] | 0 [0] | |
B.1.1.529 (omikron, N [%]) | 28 [16.5] | 1 [7.1] | |
Unknown (N [%]) | 36 [21.2] | 1 [7.1] | |
Vaccination status (N [%])c | 0.19 | ||
No vaccination | 109 [64.1] | 13 [92.9] | |
Incomplete vaccination | 5 [2.9] | 0 [0] | |
Complete vaccination | 54 [31.8] | 1 [7.1] | |
Complete vaccination and booster | 1 [0.6] | 0 [0] | |
Total days in hospital (days, median [IQR]) | 7 [7] | 22.5 [19.6] | < 0.0001 |
Delay between hospitalization and examination (days, median [IQR]) | 3 [3] | 5 [3] | 0.0018 |
Delay between first positive PCR test and examination (days, median [IQR])d | 4 [5] | 5 [3] | 0.43 |
Delay between symptom onset and examination (days, median [IQR])e | 8 [6] | 9 [4] | 0.46 |
Coma (yes, N [%]) | 1 [5.9] | 6 [42.9] | < 0.0001 |
Nosocomial infection (yes, N [%])f | 3 [1.8] | 0 [0] | > 0.99 |
Number of comorbidities (median [IQR])g | 1 [2] | 2 [1.8] | 0.20 |
Radiographic infiltrates at admission (yes, N [%])h | 97 [57.1] | 10 [71.4] | 0.25 |
Clinical scores at examination (median [IQR]) | |||
EDSSi | 1 [1.5] | 1 [1.3] | 0.39 |
MRSj | 1 [0] | NA | NA |
Barthel scalek | 100 [5] | NA | NA |
WHO clinical progression scalel | 4 [1] | 6 [3] | < 0.0001 |
INCAT disability score (overall)m | 0 [0] | NA | NA |
MRS at discharge (median [IQR])n | 1 [1] | NA | NA |
Education (years, median [IQR])o | 13.8 [6.0] | NA | NA |
MoCA total scorep (median [IQR]) | − 1.78 [0.81] | NA | NA |
SDMT z-scoreq (median [IQR]) | − 1.47 [− 1.67] | NA | NA |
Vital parameters and blood results at admission | |||
Glasgow Coma Scale (median [IQR])r | 15 [0] | 15 [0] | > 0.99 |
Oxygen saturation (%, median [IQR])s | 96 [3] | 94 [15.5] | 0.0071 |
Oxygen therapy (yes, N [%])t | 48 [28.2] | 8 [57.1] | 0.037 |
Respiratory rate (breaths/min, median [IQR])u | 18 [7] | 17 [12] | 0.89 |
Urea (md/dl, (median [IQR]) | 30 [21] | 54 [45.8] | 0.0044 |
C-reactive protein (mg/dl, median [IQR]) | 4.3 [7.6] | 10.1 [13.9] | 0.0094 |
Lymphocytes (× 1000/l, median [IQR])v | 1.06 [0.92] | 0.62 [0.25] | 0.0071 |
Procalcitonin (ng/ml, median [IQR])w | 0.10 [0.12] | 0.85 [1.64] | 0.00044 |
Troponin (ng/l, median [IQR])x | NA | 19 [58] | NA |
Ferritin (μg/l, median [IQR])y | 631.5 [694.5] | 724 [998.5] | 0.73 |
Lactate Dehydrogenase (U/l, median [IQR]) | 307 [155.8] | 466.5 [333.3] | 0.017 |
D-Dimers (mg/l_FEU, median [IQR])z | 0.73 [0.76] | 2.04 [1.78] | 0.0010 |